New Contrast Imaging Indication Considerations for Devices and Approved Drug and Biological Products: Guidance for Industry From Food and Drug Administration (FDA) πΊπΈ Guidance for Industry on new contrast imaging indication considerations for combination products and approved drug and biological products. Metadata quality: Metadata quality: Data description filled Files documentation missing License filled Update frequency not followed File formats are closed Temporal coverage filled Spatial coverage filled All files are available Learn more about this indicator Metadata quality: 66.66666666666666/100 Updated on May 14, 2020 Other (Public Domain) 0 reuses 0 favorites